Kineya announced plans to issue 7,430 share acquisition rights with consideration to directors for the purpose of enhancing long- and mid-term corporate value, potentially leading to a maximum dilution of 743,000 shares.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"9850","jir_company_name":"Kineya","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-07-16","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/07\/9850-20260716-01.pdf","jir_short_summary":"Kineya announced plans to issue 7,430 share acquisition rights with consideration to directors for the purpose of enhancing long- and mid-term corporate value, potentially leading to a maximum dilution of 743,000 shares.","jir_summary":"### Overview of Capital Policy\nKineya has decided to issue consideration-based share acquisition rights to directors and subsidiary officers to aim for the enhancement of long- and mid-term corporate value. The issuance consists of 7,430 units, with the maximum issuance of 743,000 shares upon exercise. Conditions for exercise require that either of the periods from March 2027 to March 2031 achieves an ordinary income exceeding 2.5 billion Yen, with dilution of shares aligned with shareholder interests. The issuance date is July 31, 2026, and the allocation application deadline is July 24, 2026. The exercise period runs from July 1, 2027, to June 30, 2034.\n\n### Future Outlook and Impact on Shareholders\nThe issuance of these share acquisition rights aims to promote fundamental corporate improvements and growth, pursuing sustained enhancement of corporate value. Although share dilution will occur upon achieving exercise conditions, it is expected to lead to stock price appreciation and increased corporate value. Existing shareholders are also likely to benefit from long-term corporate value growth and stock price increases, making this a vital part of the company's capital policy.","jir_financial_highlights":"Number of share acquisition rights: 7,430 units (Unknown)\nNumber of shares granted: 743,000 shares (Unknown)\nExercise price: 965 Yen (Unknown)","jir_category":"","jir_hashtags":"#Kineya, #CapitalPolicy, #JapaneseStocks","jir_key_figures":"Number of share acquisition rights: 7,430 units\nNumber of shares granted: 743,000 shares\nExercise price: 965 Yen","jir_meta_title":"\u3010Kineya\u3011Issuance of Share Acquisition Rights to Promote Long- and Mid-Term Growth | July 2026","jir_meta_description":"Kineya issues 7,430 share acquisition rights to directors, implementing a capital policy involving up to 743,000 shares of dilution aimed at enhancing long-term corporate value.","jir_og_title":"\u3010Kineya\u3011Promoting Long- and Mid-Term Growth through Share Acquisition Rights | July 2026","jir_og_description":"Kineya issues share acquisition rights to directors to enhance corporate value and maximize shareholder benefits. Details are available in the IR materials.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":57739,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"capital_policy","footnotes":""},"sector":[],"importance":[],"class_list":["post-81973","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n